Medicine & Life Sciences
Tuberculosis
100%
Alzheimer Disease
46%
Mycobacterium tuberculosis
38%
rifapentine
29%
Lovastatin
25%
HIV
23%
Isoniazid
22%
Therapeutics
21%
Directly Observed Therapy
21%
Latent Tuberculosis
21%
Cognitive Dysfunction
20%
Dementia
19%
Air
19%
Coronary Artery Disease
19%
LDL Cholesterol
19%
Pulmonary Tuberculosis
17%
T-Lymphocytes
16%
Cholesterol
16%
Geriatrics
14%
Mexican Americans
14%
HDL Cholesterol
14%
Tuberculin Test
14%
Tuberculin
12%
Gemfibrozil
12%
alirocumab
12%
Primary Prevention
11%
Biomarkers
11%
Elderly
11%
Skin Tests
11%
Education
11%
Costs and Cost Analysis
10%
Multidrug-Resistant Tuberculosis
10%
Lipids
10%
Population
10%
Lung
9%
Students
9%
Interleukin-18
9%
Interferons
9%
Hypoxia
9%
Placebos
8%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8%
HIV Infections
8%
Health
8%
Odds Ratio
8%
Mycobacterium tuberculosis antigens
8%
Serum
8%
CD4 Lymphocyte Count
8%
Confidence Intervals
8%
Pharmaceutical Preparations
8%
HIV-1
7%
Randomized Controlled Trials
7%
Acute Coronary Syndrome
7%
Accidental Falls
7%
Infections
7%
Heart Rate
7%
Immunization
6%
Health Care Costs
6%
Delivery of Health Care
6%
Quality Improvement
6%
Primary Health Care
6%
Recurrence
6%
Cyclic AMP Response Element-Binding Protein
6%
Canada
6%
Child
6%
Peptides
5%
Immunosuppressive Agents
5%
Lipoproteins
5%
Vaccination
5%
Vascular Dementia
5%
Respiration
5%
Reperfusion Injury
5%
Hospitalization
5%
Natural Killer Cells
5%
rifamycin SV
5%
Rifampin
5%
Interleukin-15
5%
Monocytes
5%
Comparative Physiology
5%
Mexico
5%
C-Reactive Protein
5%
Natural Cytotoxicity Triggering Receptor 1
5%
Hispanic Americans
5%